Serum Aspergillus Galactomannan for the Management of Disseminated Histoplasmosis in AIDS - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue American Journal of Tropical Medicine and Hygiene Année : 2012

Serum Aspergillus Galactomannan for the Management of Disseminated Histoplasmosis in AIDS

Résumé

Disseminated histoplasmosis is an emerging infection in patients with cellular immune deficiency in non-endemic countries, caused by the migration from endemic regions and the development of travels. Diagnosis can be challenging in this context because rapid diagnostic tools such as Histoplasma antigen detection or appropriate molecular tools are generally unavailable, serology is often negative in immunosuppressed patients, and isolation of the fungus from cultures often takes several weeks. Here, we report the contribution of galactomannan serum detection for the management of an HIV-infected patient with disseminated histoplasmosis.

Dates et versions

pasteur-02870296 , version 1 (16-06-2020)

Identifiants

Citer

Sébastien Rivière, Blandine Denis, Marie-Elisabeth Bougnoux, Fanny Lanternier, Marc Lecuit, et al.. Serum Aspergillus Galactomannan for the Management of Disseminated Histoplasmosis in AIDS. American Journal of Tropical Medicine and Hygiene, 2012, 87 (2), pp.303-305. ⟨10.4269/ajtmh.2012.12-0119⟩. ⟨pasteur-02870296⟩

Collections

PASTEUR
20 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More